Dr Katie Hall PhD I am principally interested in the field of behavioural neurosciences with a particular focus in understanding how neurodegenerative pathologies cause dementia symptoms and behavioural dysfunction, as well as developing potential neuroprotective t...
Dr Maria Herva Moyano E I have developed a fast and reliable method to form alpha-synuclein aggregates and my aim is to use it as a high content assay to screen for drugs with anti aggregating properties. I am specially interested in the option of repurposing existing dr...
Professor David Klenerman Small soluble protein aggregates are thought to play a key role in the initial development of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, but are difficult to study using conventional methods due to their low concent...
Dr Ru Tian IMAGING ALPHA-SYNUCLEIN OLIGOMERS IN PARKINSON’S DISEASE BRAINS
To date, the molecular origins of PD are not fully understood and no disease-modifying treatments are available. Although Lewy bodies are relatively inert, smaller soluble assemblies...